DF-003(Drug Farm)

N/A

Report date: 2026/03/31 20:00:21
NMEFirst In Class

Base Information

Drug NameDF-003(Drug Farm)
Drug Alias Name(S)-N-(4-(2-(4-chlorophenyl)but-3-yn-2-yl) thiazol-2-yl)-2,6-difluoro-4-(piperazin-1-yl) benzamideDF-003DF-003(Drug Farm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-protein kinase 1 inhibitors
TargetsAlpha-protein kinase 1
Therapy Area/IndicationsROSAH syndromeInflammationRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Drug Farm Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Drug Farm Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsROSAH syndromeInflammationRenal Insufficiency, Chronic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A